High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Authors :: Seldin DC
Andrea N
Berenbaum I
Berk JL
Connors L
Dember LM
Doros G
Fennessey S
Finn K
Girnius S
Lerner A
Libbey C
Meier-Ewert HK
O'Connell R
O'Hara C
Quillen K
Ruberg FL
Sam F
Segal A
Shelton A
Skinner M
Sloan JM
Wiesman JF
Sanchorawala V
Source :: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2011 Jun; Vol. 18 Suppl 1, pp. 127-9.
Publication Year :: 2011

Subjects :: Amyloidosis drug therapy
Amyloidosis immunology
Amyloidosis physiopathology
Amyloidosis surgery
Combined Modality Therapy
Dose-Response Relationship, Drug
Humans
Survival Rate
Transplantation, Autologous
Amyloidosis therapy
Immunoglobulin Light Chains
Stem Cell Transplantation

Language :: English
ISSN :: 1744-2818
Volume :: 18 Suppl 1
Database :: MEDLINE
Journal :: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Publication Type :: Academic Journal
Accession number :: 21838459
Full Text :: https://doi.org/10.3109/13506129.2011.574354047

Full Text Access

Tools